The type of papers published in the journal will remain unchanged-both clinical studies, reviews,
A change of editorship is always likely to have some influence on the strategy of a journal. In this case, however, our joint editorship will continue many of the aims established by Dr. Tim Betts, who has made Seizure a recognised journal for European epileptology and one with a global influence. We are very grateful for his hard work in establishing the journal, for his endurance and his passion for important developments in epileptology. We can only try to match his achievements.
At the start of our editorship, we should clarify the status quo for the journal:
• the latest Impact Factor for Seizure is 1.399, ranking it 68 of 138 Clinical Neurology journals;
• approximately 200 manuscripts were submitted to the journal during 2003;
• the journal's acceptance rate was approximately 50% during 2003;
• there is a very active group of section editors, editorial board and referees.
Our primary aims are to:
• raise the reputation of Seizure as an international journal for epileptology;
• continue to meet the information needs of the journal's readers but at the same time, make Seizure accessible to a true international audience beyond Europe;
• increase the number of referees.
Clearly, the above are related to the nature of manuscripts submitted to the journal, and we hope that future months will see increased submissions now that Seizure offers e-submission for authors via Elsevier's AuthorGateway (http://authors.elsevier. com/journal/seizure).
e-submission via the AuthorGateway is our preferred route to receive manuscripts, but for a transition period we will accept some manuscripts via e-mail (only when there is no operational access to Internet) to our new Editorial Office Assistant, Ms. Hettie van Ek, in Kempenhaeghe at Seizure@ kempenhaeghe.nl.
